Lord, Abbett & Co
THC icon

Lord, Abbett & Co’s Tenet Healthcare THC Stock Holding History

Lord, Abbett & Co’s Portfolio THC Stock Details THC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-210,518
Closed -$35M – 580
2024
Q3 		$35M Sell
210,518
-33,306
-14% -$5.04M 0.11% 225
2024
Q2 		$32.4M Sell
243,824
-181,008
-43% -$21.8M 0.11% 236
2024
Q1 		$44.7M Sell
424,832
-68,577
-14% -$6.16M 0.14% 195
2023
Q4 		$37.3M Buy
493,409
+102,829
+26% +$6.52M 0.13% 215
2023
Q3 		$25.7M Sell
390,580
-41,141
-10% -$3.08M 0.1% 286
2023
Q2 		$35.1M Sell
431,721
-190,086
-31% -$13.5M 0.12% 244
2023
Q1 		$36.9M Buy
621,807
+11,760
+2% +$654K 0.13% 232
2022
Q4 		$29.8M Sell
610,047
-19,543
-3% -$903K 0.11% 269
2022
Q3 		$32.5M Buy
629,590
+16,915
+3% +$1M 0.12% 230
2022
Q2 		$32.2M Sell
612,675
-230,614
-27% -$16M 0.11% 246
2022
Q1 		$72.5M Buy
843,289
+538,206
+176% +$44.2M 0.19% 160
2021
Q4 		$24.9M Buy
305,083
+109,880
+56% +$8.03M 0.06% 366
2021
Q3 		$13M Buy
+195,203
New +$13.8M 0.03% 482

Other funds holding THC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Lord, Abbett & Co's THC Position: Q4 2024 in Review

Lord, Abbett & Co sold out of Tenet Healthcare (THC) in Q4 2024, closing a stake of 210,518 shares — an estimated $35M sold.

Lord, Abbett & Co first reported a position in THC in Q3 2021 and held it in 13 quarters. The position peaked at $72.5M in Q1 2022. 578 funds tracked by Wall St. Rank hold THC as of Q4 2024.

  • Lord, Abbett & Co reported no remaining Tenet Healthcare position as of Q4 2024 after selling out during the quarter.
  • Lord, Abbett & Co sold 210,518 Tenet Healthcare shares in Q4 2024, an estimated $35M.
  • Lord, Abbett & Co first reported a position in Tenet Healthcare in Q3 2021 and held it in 13 quarters.
  • Lord, Abbett & Co's Tenet Healthcare position peaked at $72.5M in Q1 2022.
  • 578 funds tracked by Wall St. Rank held Tenet Healthcare as of Q4 2024.

Based on Lord, Abbett & Co's 13F filing for Q4 2024, filed 14 Feb 2025.